Kurogi, Kazumasa
Ishii, Masanobu
Yamamoto, Nobuyasu
Yamanaga, Kenshi
Tsujita, Kenichi
Article History
Received: 6 December 2020
Accepted: 8 December 2020
First Online: 17 January 2021
Compliance with ethical standards
:
: Dr. Tsujita has received remuneration for lecture from Amgen Astellas BioPharma K.K., Kowa Pharmaceutical Co. Ltd., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Pfizer Japan Inc., Bristol-Myers K.K., MSD K.K.; has received trust research/joint research funds from Bristol-Myers K.K., Sugi Bee Garden Co., Ltd., Kowa Pharmaceutical Co. Ltd.; and has received scholarship fund from ITI Co., Ltd., Abbott Medical Japan L.L.C, Abbott Vascular Japan Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Cardinal Health Japan, Kaneka Medix Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma, Chugai Pharmaceutical Co., Ltd., TERUMO Co., Ltd., NIPRO CORPORATION, NIHON KOHDEN CORPORATION, Medtronic Japan Co., Ltd., Japan Lifeline Co., Ltd., Fides-One, Inc., Fukuda Denshi Co., Ltd., and Boston Scientific Japan K.K. All the other authors have nothing to disclose.